Alfred Reszka, Merck & Co.
Alfred Reszka, Executive Director and Head, Strategic Business Intelligence, Merck & Co.
Alfred “Al” Reszka is Executive Director and Head, Strategic Business Intelligence at Merck. He and his team include clients from R&D to marketing and manufacturing across a variety of business functions requiring scientific, medical and business intelligence. Roles and responsibilities include strategic benchmarking and strategy development, product surveillance, biosimilars, Diversified Brands, emerging markets, Osteoporosis and women’s health licensing, business development, and M&A.
Prior to joining the Global Competitive Intelligence group in 2007, Dr. Reszka was Senior Research Fellow in Bone Basic Research at Merck, where he conducted research into the mechanism of action of FOSAMAX and lead the drug discovery effort. He joined Merck in 1997 after conducting postdoctoral research on molecular signal transduction with Nobel Laureates, Edmund Fischer and Edwin Krebs at the University of Washington in Seattle. Dr. Reszka earned his PhD in 1992 at the University of Illinois, Champaign-Urbana.
Sue Ward, Pfizer
Sue Ward, Senior Director, Worldwide Competitive Intelligence, Pfizer
Sue Ward is currently Senior Director of Worldwide Competitive Intelligence within Pfizer’s Corporate Strategic Planning group. Previously within Pfizer, Sue led the competitive intelligence team within Information & Knowledge Management. Prior to joining Pfizer, Sue worked in the UK as Associate Director of Competitive Analysis for SmithKline Beecham (SB)(now GSK). Other positions held by Sue within SB included managing a Clinical Information group and the Product Literature Information Service. Sue now holds a BSc (Hons) in Biology from University College London and an MSc in Information Science from The City University, London.